中国心理卫生杂志2024，Vol.38Issue(1)：9-15,7.DOI:10.3969/j.issn.1000-6729.2024.01.002
精神分裂症、抑郁症和双相障碍住院患者的疾病成本
Disease costs in inpatients with schizophrenia,major depressive disorder,and bipolar disorder
摘要
Abstract
Objective:To evaluate direct and indirect costs for schizophrenia,major depressive disorder(MDD)and bipolar disorder,and to compare their differences of cost composition,and to explore the drivers of the total costs.Methods:A total of 3 175 inpatients with schizophrenia,MDD,and bipolar disorder were recruited.In-patient's self-report total direct of medical costs outpatient and inpatient,out-of-pocket costs,and direct non-medical costs were regarded as direct costs.Productivity loss and other loss caused by damaging properties were defined as indirect costs.The perspectives of this study included individual and societal levels.Multivariate regression analysis was applied for detecting the factors influencing disease costs.Results:The total cost of schizophrenia was higher than those of MDD and bipolar disorder at individual and societal levels.The indirect costs of three mental disorders were higher than the direct costs,and the indirect cost ratio of bipolar disorder was higher than those of schizophre-nia and MDD.Age,gender,working condition and marital status(P＜0.05)were the important drivers of total costs.Conclusion:The economic burden of the three mental disorders is relatively heavy.Schizophrenia has heaviest disease burden,and the productivity loss due to mental disorders is the driving force of the soaring disease cost关键词
精神分裂症/抑郁症/双相障碍/疾病成本Key words
schizophrenia/major depressive disorder/bipolar disorder/disease cost分类
医药卫生引用本文复制引用
吴国平,刘波,卢瑾,赵紫建,梁宇航,王丽波,李斌,姜林伶,李中才,刘肇瑞,魏景明,黄悦勤,张婷婷,何燕玲,周亮,章杰,龚元东,刘燕..精神分裂症、抑郁症和双相障碍住院患者的疾病成本[J].中国心理卫生杂志,2024,38(1):9-15,7.基金项目
国家重点研发计划(2017YFC0907800) （2017YFC0907800）
